Skip to main content
Equibles

Capital Research Global Investors

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1422848 Los Angeles, CA
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$9,681,584,117
+$247,996,153 QoQ
Shares Held
19,490,637
-7.7% QoQ
Ownership
7.69%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#3
of 1,745 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Capital Research Global Investors holds $14,161,458,348 across 17 Biotechnology names. VRTX ranks #1 (68.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		19,490,637 $9,681,584,117
2 ALNY
Alnylam Pharmaceuticals, Inc.
 9,750,699 $2,935,252,919
3 BMRN
Biomarin Pharmaceutical Inc
 3,504,387 $200,521,024
4 IDYA
IDEAYA Biosciences, Inc.
 5,344,701 $199,197,006
5 TECH
BIO-TECHNE Corp
 2,621,890 $185,236,528
6 RYTM
Rhythm Pharmaceuticals, Inc.
 1,532,303 $170,131,602
7 KYMR
Kymera Therapeutics, Inc.
 1,388,881 $159,262,984
8 CYTK
Cytokinetics Inc
 1,686,625 $143,683,583

All Filings in VRTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,681,584,117 19,490,637
2026-03-31 $9,433,587,964 21,125,964
2025-12-31 $7,850,537,715 17,316,344
2025-09-30 $6,482,926,970 16,553,281
2025-06-30 $7,171,411,153 16,108,291
2025-03-31 $7,047,510,298 14,536,344
2024-12-31 $4,199,738,567 10,428,951
2024-09-30 $4,186,745,501 9,002,205
2024-06-30 $4,002,558,976 8,539,339
2024-03-31 $2,401,000,114 5,743,882
2023-12-31 $1,451,646,804 3,567,664
2023-09-30 $1,172,782,360 3,372,584
2023-06-30 $1,077,434,401 3,061,676
2023-03-31 $255,173,617 809,895
2020-09-30 $340,329,054 1,250,658
2020-06-30 $363,078,814 1,250,659
2020-03-31 $297,595,498 1,250,664